Related Experiment Video

Updated: Jul 15, 2026

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction

Silvia Del Ry1, Daniela Giannessi, Maristella Maltinti

  • 1Institute of Clinical Physiology, National Research Council, Pisa, Italy. delry@ifc.cnr.it

Peptides
|April 13, 2007
PubMed

Insights

C-type natriuretic peptide (CNP) is elevated in patients with left ventricular systolic dysfunction, regardless of heart failure severity. Elevated CNP correlates with impaired heart function and endothelial damage.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biochemistry

Background:

  • C-type natriuretic peptide (CNP) is produced by vascular endothelium.
  • The role of CNP in idiopathic left ventricular systolic dysfunction (ILVDys) is not well understood.
  • Investigating CNP's association with myocardial and endothelial dysfunction in ILVDys is crucial.

Purpose of the Study:

  • To determine plasma CNP levels in patients with ILVDys.
  • To assess the relationship between CNP and indicators of myocardial and endothelial/microvascular impairment in ILVDys.
  • To explore CNP's correlation with heart failure severity and cardiac function parameters.

Main Methods:

  • Plasma CNP levels were measured in 51 ILVDys patients and 60 controls.
  • Correlations were analyzed between CNP levels and echocardiographic parameters (LVEF, end-diastolic dimension).
  • Associations with other biomarkers (ANP, BNP, IL-6) and lipid profiles were examined, along with coronary microcirculation capacity in a subgroup.

Main Results:

  • Plasma CNP levels were significantly increased in ILVDys patients (with or without heart failure) compared to controls.
  • CNP levels correlated significantly with LVEF, end-diastolic dimension, ANP, BNP, and IL-6.
  • CNP also showed associations with lipid profiles and impaired coronary microvascular function.

Conclusions:

  • CNP is activated in patients with LV dysfunction without coronary artery disease, irrespective of heart failure.
  • CNP levels reflect the extent of myocardial functional impairment in these patients.
  • Elevated CNP is linked to both systemic and coronary endothelial/microvascular damage in ILVDys.

More Related Videos

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...